Princess Margaret Cancer Centre — Toronto

Public research footprint of Princess Margaret Cancer Centre, compiled from the ClinicalTrials.gov public registry.

886

Registered studies

451

Active

237

Recruiting now

306

Completed

109

Stopped or withdrawn

Most-studied conditions

NSCLC (Advanced Non-small Cell Lung Cancer) · Breast Neoplasms · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or… · Urothelial Carcinoma of the Renal Pelvis and Ureter

Recently updated registry entries

NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)
NCT06510374 — Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Princess Margaret Cancer Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.